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Recruitment of primordial follicles is essential for female fer-
tility; however, the exact mechanisms regulating this process
are largely unknown. Earlier studies using anti-Mu¨llerian
hormone (AMH)-deficient mice suggested that AMH is in-
volved in the regulation of primordial follicle recruitment. We
tested this hypothesis in a neonatal ovary culture system, in
which ovaries from 2-d-old C57Bl/6J mice were cultured for 2
or 4 d in the absence or presence of AMH. Ovaries from 2-d-old
mice contain multiple primordial follicles, some naked oo-
cytes, and no follicles at later stages of development. We ob-
served that in the cultured ovaries, either nontreated or AMH-
treated, follicular development progressed to the same extent
as in in vivo ovaries of comparable age, confirming the validity
of our culture system. However, in the presence of AMH, cul-
tured ovaries contained 40% fewer growing follicles compared
with control ovaries. A similar reduction was found after 4 d
of culture. Consistent with these findings, we noted lower
inhibin -subunit expression in AMH-treated ovaries com-
pared with untreated ovaries. In contrast, expression of AMH
ligand type II receptor and the expression of oocyte markers
growth and differentiation factor 9 and zona pellucida protein
3 were not influenced by AMH.
Based on the results, we suggest that AMH inhibits initia-
tion of primordial follicle growth and therefore functions as
an inhibitory growth factor in the ovary during these early
stages of folliculogenesis. (Endocrinology 143: 1076–1084,
2002)
FOR FEMALE MAMMALS, the finite number of primor-dial follicles available during reproductive life is es-
tablished during fetal development (human) (1) or just after
birth (mouse, rat) (2, 3). Factors involved in the initiation of
primordial follicle growth, a process also known as initial
recruitment (4), have long remained unknown. Recently,
however, it was shown that stem cell factor (SCF, or Kit-
ligand) (5), growth and differentiation factor 9 (GDF9) (6),
basic fibroblast growth factor (bFGF) (7), and nerve growth
factor (NGF) (8) promote initiation of primordial follicle
growth. Also, anti-Mu¨llerian hormone (AMH) has been im-
plicated in primordial follicle recruitment from analysis of
AMH null ovaries (9). AMH is a member of the TGF su-
perfamily of growth and differentiation factors (10) and is
responsible for Mu¨llerian duct regression during male fetal
development (11). This ligand-receptor system is also found
in the ovary with expression of both the AMH ligand and its
type II receptor (AMHRII) postnatally in granulosa cells of
mainly nonatretic preantral and small antral follicles (12, 13).
In addition, AMHRII is also expressed in the prenatal ovary
(14). Examination of ovarian follicles in AMH-deficient fe-
male mice revealed lower numbers of primordial follicles
and more growing follicles compared with wild-type litter-
mates. These findings led to the proposal that AMH inhibits
primordial follicle recruitment (9).
In this study, we examined the ability of AMH to inhibit
primordial follicle recruitment in cultured neonatal mouse
ovaries. To this end, we developed a neonatal ovary culture
system, in which follicular development progresses to the
same extent as in in vivo ovaries of comparable age. In this
system, we characterized primordial follicle recruitment by
the determination of the number of primordial and growing
follicles in neonatal ovaries after 2 and 4 d of culture in the
presence or absence of recombinant AMH. The effects of
AMH on primordial follicle recruitment was also investi-
gated by assessing AMHRII and inhibin -subunit transcript
expression and additional oocyte-specific markers, such as
GDF9 and zona pellucida protein 3 (ZP3).
Collectively, results from these studies suggest that AMH
is a potent inhibitor of primordial follicle recruitment.
Materials and Methods
AMH production
Human embryonic kidney 293 (HEK293) cells were stably transfected
with a cDNA encoding His-tagged rat AMH inserted in the pRc/cyto-
megalovirus expression vector. The AMH cDNA contained an opti-
mized cleavage site that yields maximal amounts of cleaved mature
AMH (15, 16). HEK293 cells were cultured in DMEM/F-12 (Life Tech-
nologies, Inc., Paisley, Scotland, UK) supplemented with 5% FCS, pen-
icillin (400 IU/ml), streptomycin (0.4 mg/ml), and neomycin G418 (0.4
mg/ml). At a cell confluence of about 80–90%, the medium was replaced
by medium without FCS. After 4 d, the medium was collected and
proteins with a molecular mass above 10 kDa were concentrated ap-
Abbreviations: AMH, Anti-Mu¨llerian hormone; AMHII, AMH ligand
type II receptor; bFGF, basic fibroblast growth factor; GAPDH, glycer-
aldehyde 3-phosphate dehydrogenase; GDF9, growth and differentia-
tion factor 9; NGF, nerve growth factor; RT, room temperature; SCF,
stem cell factor; ZP3, zona pellucida protein 3.
0013-7227/02/$15.00/0 Endocrinology 143(3):1076–1084
Printed in U.S.A. Copyright © 2002 by The Endocrine Society
1076
 at Medical Library Erasmus MC on November 20, 2006 endo.endojournals.orgDownloaded from 
proximately 35-fold using a Centriprep10 filter system (Millipore Corp.,
Bedford, MA).
The amount of AMH was measured by ELISA making use of the
His-tag, with the Bio-Rad Laboratories, Inc. (Hercules, CA) 3,35,5-
tetramethylbenzidine peroxidase enzyme immunoassay substrate kit.
The primary antibody, pentaHis monoclonal antibody (raised in rabbit;
QIAGEN GmbH, Hilden, Germany), was used at 100 ng/ml. The sec-
ondary antibody, a goat-antimouse IgG peroxidase conjugate (Sigma, St.
Louis, MO), was used at a 1:1000 dilution. The amount of AMH was
calibrated using the same standard preparation of His-tagged AMH in
every ELISA and was expressed in arbitrary units. The concentrated
supernatant of wild-type HEK293 cells was used as control medium.
The presence or absence of AMH in the media used in the experiments
was investigated by Western blotting using a primary polyclonal anti-
body against AMH (raised in goat; C-20, Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA) at a 1:2000 dilution and a secondary peroxidase-con-
jugated mouse antigoat/sheep antibody (Sigma) at a dilution of 1:10000.
The AMH preparations (800 U/ml) were shown to be bioactive using
a Mu¨llerian duct regression assay (15, 16) (data not shown).
Animals and ovary organ culture
C57Bl/6J female mice were used in all experiments described in this
report. For the ovary organ culture experiments, ovaries of 2-d-old
females were used because these ovaries predominantly contain pri-
mordial follicles, some naked oocytes and no growing follicles. Day of
birth was denoted as d 1. The animals were obtained from the Animal
Facility of the Faculty of Medicine and Health Sciences of the Erasmus
University Rotterdam and were kept under standard animal housing
conditions in accordance with the NIH guidelines for the Care and Use
of Experimental Animals. Animals were killed by decapitation.
Ovaries of 2-d-old mice were either immediately fixed in Bouin’s
fixative for morphological examination and follicle counting, or snap-
frozen in liquid nitrogen for RNA isolation, or placed in culture. An
organ culture method was used as described by Cooke et al. (17), which
was modified in our laboratory with the help of Dr. Judith Emmen (18).
The ovaries, together with some surrounding tissue, were removed from
the abdomen under a dissection microscope. The tissue was placed in
watch-glasses containing PBS. With the help of two syringe needles, the
tissue surrounding the ovaries, including the capsule in which the ovary
is enclosed (periovarian sac), was removed. Because large interanimal
variation in the number of follicles per ovary was observed (see Results),
ovaries of each animal were matched and one was used for control
cultures and the other for treated cultures. Ovaries were cultured in a
four-well culture plate (Nunc plate, Applied Scientific, South San Fran-
cisco, CA). Each well contained 0.5 ml DMEM/F-12 medium with
GLUTAMAX-I (Life Technologies, Inc.) supplemented with 1% (vol/
vol) charcoal-stripped FCS, insulin (10 g/ml), and transferrin (10 g/
ml; Sigma). Penicillin (250 IU/ml), streptomycin (0.25 mg/ml), and
fungizone (3.1 g/ml) (BioWhittaker, Walkersville, MD) were added to
the culture medium to prevent bacterial contamination. No effect of the
charcoal stripped FCS was found in the sensitive fetal Mu¨llerian duct
regression assay, whereas by Western blotting no AMH could be de-
tected in the charcoal-stripped FCS. Each ovary was placed in a small
droplet of medium (approximately 15 l) on a piece of 0.4-m Millicel-
cellular matrix filter (Millipore Corp.) of approximately 1 cm2, floating
on the culture medium. The ovaries were cultured at 37 C in a humid-
ified atmosphere containing 5% CO2 for 2 or 4 d. Of each pair of ovaries
(derived from one animal), one ovary was cultured in medium con-
taining concentrated medium of wild-type HEK293 cells (control),
whereas the other ovary was cultured in medium containing concen-
trated medium of HEK293 cells producing rat AMH (800 U/ml).
After 2 d of culture, the medium was removed and fresh medium was
added. At the end of the culture period, the ovaries were either fixed for
2 h in Bouin’s fixative or snap frozen in liquid nitrogen and stored at80
C. Ovaries of 2-, 4-, and 6-d-old C57Bl/6J mice were used for comparison
of the development of follicles in the culture experiments, hereby fo-
cusing on the developmental stage of the follicles. No comparison was
made regarding the number of primordial and growing follicles between
cultured ovaries and freshly isolated ovaries of comparable age.
Ovarian histology and follicle counting
To investigate the development of ovarian follicles in the cultured
ovaries and to compare it with follicle development in vivo, fresh and
cultured ovaries were fixed for 2 h in Bouin’s fixative, embedded in
paraffin after routine histological procedures, and 8-m serial sections
were mounted on slides and stained with hematoxylin and eosin.
Primordial follicles are nongrowing follicles and consist of an oocyte
partially or completely encapsulated by flattened squamous pregranu-
losa cells. Early primary follicles have initiated development and contain
at least one cuboidal (enlarged) granulosa cells (19). In addition, pri-
mordial follicles and early primary follicles were distinguished by size:
follicles with a mean diameter less than or equal to 20m were classified
as primordial follicles, whereas follicles with a mean diameter greater
than 20 m were classified as growing follicles (primary and secondary
follicles). This borderline of 20m was established in a pilot experiment.
The mean diameter of the follicles was determined by measuring two
perpendicular diameters (20). All primordial follicles were counted in
every second section, whereas in every second section of the growing
follicles only those in which the nucleus of the oocyte was clearly visible
were counted. We did not attempt to distinguish between nonatretic and
atretic follicles because at this stage of follicle development, atresia is not
apparent by histology. Both 2- and 4-d culture experiments were per-
formed twice.
Immunohistochemistry of AMH and inhibin -subunit
To determine the onset of AMH and inhibin -subunit protein ex-
pression in vivo and in cultured neonatal mouse ovaries, immunohis-
tochemistry was performed on freshly isolated 1- to 6-d-old mouse
ovaries and on 2-d-old mouse ovaries cultured for 2 or 4 d. Of every
group, four ovaries were examined, which were derived from two
different animals.
The ovaries were fixed for 2 h in Bouin’s fixative, embedded in
paraffin, and 8-m sections were made. Sections were mounted on slides
coated with 3-aminopropyl triethoxysilane (Sigma). After deparaffiniza-
tion, sections were quenched for 12 min in 3% H2O2/methanol solution
to block endogenous peroxidase activity and transferred to PBS. For
AMH immunohistochemistry, the sections were microwaved for 3  5
min at 700 W in 0.01 m citric acid monohydrate buffer, pH 6.0 (Merck,
Darmstadt, Germany), cooled down to room temperature (RT), and
subsequently rinsed in PBS. For AMH immunohistochemistry, the sec-
tions were preincubated with normal rabbit serum in 5% (wt/vol) BSA
(DAKO Corp., Glastrup, Denmark) for 15 min at RT, and for inhibin
-subunit immunohistochemistry, the sections were preincubated with
normal swine serum in 5% BSA (DAKO Corp.) for 15 min at 37 C. For
AMH immunohistochemistry, the preincubation step was followed by
incubation at 4 C overnight with primary polyclonal antibody against
MIS (C-20; Santa Cruz Biotechnology, Inc.), diluted 1:1000 in 5% BSA in
PBS. The antibody was raised against a peptide mapping at the carboxy
terminus of human AMH, which differs from the corresponding mouse
sequence, by a single amino acid. For inhibin -subunit immunohisto-
chemistry, the preincubation step was followed by incubation at 37 C for
30 min with primary polyclonal antibody AS173–11, diluted 1:40 in 5%
BSA in PBS. This primary polyclonal antibody was raised against amino
acids 37–55 of the rat inhibin pre-pro--subunit. After incubation, the
sections were rinsed in PBS and subsequently treated for 30 min at RT
either with biotinylated rabbit antigoat antibody (dilution: 1:400; DAKO
Corp.) for AMH immunohistochemistry or with biotinylated swine an-
tirabbit antibody (dilution 1:400; DAKO Corp.) for inhibin -subunit
immunohistochemistry. Finally, a treatment with streptavidin-biotin-
peroxidase complex (diluted 1:200 in PBS; DAKO Corp.) for 30 min at
RT followed. Peroxidase activity was developed with 0.07% 3,3-
diaminobenzidine tetrahydrochloride (Fluka, Basel, Switzerland) for 5–7
min. In each experiment, control sections were incubated with 5% BSA/
PBS in the absence of the primary antibody (negative control). Hema-
toxylin/eosin was used for counterstaining. Ovaries from 30-d-old mice,
containing many AMH and inhibin -subunit-positive follicles, were
used as a positive control.
RNA isolation and RNase protection assay
Freshly isolated 2-, 4-, and 6-d-old ovaries or 2-d-old ovaries that were
cultured for 2 or 4 d in the absence or presence of added AMH were snap
Durlinger et al. • AMH Inhibits Primordial Follicle Recruitment Endocrinology, March 2002, 143(3):1076–1084 1077
 at Medical Library Erasmus MC on November 20, 2006 endo.endojournals.orgDownloaded from 
frozen in liquid nitrogen and stored at 80 C. Two separate RNase
protection assays were performed. In each assay, different sets of total
RNA were used. For each assay, total RNA was isolated from 20 ovaries
per culture condition, 20 ovaries of 2-, 4-, and 6-d-old mice and 5 ovaries
of 30-d-old. Total RNA was isolated using Trizol Reagent (Life Tech-
nologies, Inc.), which is an improvement of the single-step RNA isolation
method developed by Chomczynski and Sacchi (21). The isolated RNA
was dissolved in 10 l deionized H2O and stored by 80 C.
Mouse ZP3 and mouse inhibin -subunit DNA templates for in vitro
transcription were generated by RT-PCR. The RT-PCR reaction was
carried out on 2.5 g total RNA, extracted from 30-d-old mouse ovaries,
using random hexamers. A sample of the RT reaction product was used
in the PCR reaction. With the help of ZP3 primers 5-GACTTCCACG-
GTTGCCTTG-3, annealing to nucleotide sequence 735–753 of the Zp3
gene (numbering according to GenBank sequence), and 5-GCAGTC-
CAG-CCTTCC-ACAG-3, annealing to antisense sequence 1174–1156, a
440-bp fragment was generated. For the inhibin -subunit, PCR primers
5-GCCATCCCAACACATACG-3, annealing to sense sequence 374–
391, and 5-GAAACTGGGAGGGTGTACG-3, annealing to antisense
sequence 884–866, were used to generate a 511-bp fragment. These
fragments were inserted into the PCR2.1-TOPO vector. A fragment of
521 bp of the PCR2.1-TOPO vector containing the ZP3 PCR product was
removed from PCR2.1-TOPO vector by cutting the plasmid with BamHI
and XhoI, whereas a fragment of 538 bp containing inhibin -subunit
PCR product was removed by cutting the PCR2.1-TOPO vector with
EcoRI. Both fragments were subsequently subcloned in pBluescript KS
and used to generate a [32P]-uridine triphosphate-labeled antisense RNA
probe.
Mouse GDF9 DNA template (22) was kindly donated by Dr. O. Ritvos
(Helsinki, Finland). This template was used to obtain a PCR fragment
of 411 bp, containing a part of 293-bp of mouse GDF9 construct and a
part of pGEM-T vector containing the T7 polymerase site. The primers
used in this PCR reaction were primer 5-CAGGGTTTTCCCAGTCAC-
3, annealing to the sense sequence 2937–2954 located within the
pGEM-T vector and primer 5-CTGCCATGGAACACTTGCTC-3, an-
nealing to the antisense sequence 490–471 located within the GDF9
construct. This PCR product was used as template for the construction
of a GDF9 [32P]-uridine triphosphate-labeled antisense RNA probe.
Mouse AMHRII antisense probe was generated as described before (23).
The control glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
RNA probe was synthesized using a construct containing 163 bp AccI-
Sau3AI fragment of the rat GAPDH cDNA.
RNase protection assays were performed on total RNA, extracted
from fresh and cultured mouse ovaries, as described by Baarends (14).
GAPDH was used as a control for RNA loading. The relative amount of
protected mRNA band was quantified through exposure of the gels to
a phosphor screen (Molecular Dynamics, Inc., B & L Systems, Zoeter-
meer, The Netherlands) and using PhosphorImager, and ImageQuant
(Molecular Dynamics, Inc.) as computer analysis software. The mRNA
levels were normalized to those for GAPDH mRNA and are expressed
as a percentage of the mRNA level of 2-d-old ovaries, which was con-
sidered 100%.
Two separate assays were performed, using RNA derived from two
separate culture experiments. In every assay, 5 l of the RNA samples
were hybridized with inhibin -subunit and GAPDH probes, and the
remaining 5 l with probes for AMHRII, GDF9, ZP3 and GAPDH. Total
RNA of 30-d-old mouse ovaries was used as a control.
Statistical analysis
Results are presented as the mean  sem. The data were evaluated
for statistical differences by an independent samples t test using SPSS,
Inc.9.0 (SPSS, Inc., Chicago, IL) computer software. Differences were
considered significant at P  0.05.
Results
AMH production
To ensure that no AMH is present in the concentrated
control medium, and that AMH is present in the concen-
trated medium of rat AMH-producing HEK293 cells, the
concentrated media were examined by Western blot analysis
using an AMH antibody. Figure 1 shows the result of this
analysis. There is no AMH in lane 1, containing concentrated
control medium, whereas two bands representing AMH pro-
tein can be seen in lane 2 containing concentrated medium
of rat AMH-producing HEK293 cells. The lower band is the
monomeric form of mature AMH (12 kDa), whereas the top
band is nonreduced AMH dimer (24 kDa). The absence of
larger bands indicates complete cleavage of the proform of
AMH.
Culture medium from both control and AMH-treated cul-
tures was also examined by Western blot analysis to check
for the presence of endogenous AMH and to make sure that
the added rat AMH is not degraded during the culture. No
AMH was found in the control cultures, whereas nonde-
graded AMH was present in the AMH-treated cultures (re-
sults not shown).
Ovary organ culture and ovarian morphology
The culture system was evaluated by comparing the mor-
phology of 2-d-old ovaries cultured for 2 or 4 d with the
morphology of in vivo ovaries of corresponding age, which
were isolated from 4- and 6-d-old mice, respectively. This
evaluation focused on the developmental stage of the folli-
cles, whereas no comparison was made regarding the num-
ber of different stages of follicles.
Ovaries of 2-d-old mice, which were used for the ovary
culture experiments, predominantly contain primordial fol-
licles, some naked oocytes, and no growing follicles (Fig. 2A).
Histological examination of the ovaries after 2 or 4 d of
culture indicated that the culture conditions had no pro-
nounced detrimental effect on the ovarian tissue, i.e. almost
no necrosis or apoptotic cells were found (Fig. 2B). After 2 d
of culture, the ovaries contained many primordial follicles
but also some primary follicles of different sizes (Fig. 2D),
whereas after 4 d of culture, the ovaries contained in addition
to primordial and many primary follicles also some early
secondary follicles (Fig. 2F). Most primordial follicles were
located in the cortical part of the ovary, whereas the primary
and secondary follicles (further referred to as growing fol-
licles) were mostly found in the central part of the ovary (Fig.
2B). As a further validation of the culture system, we com-
pared ovaries of similar ages, i.e. ovaries cultured for 2 or 4 d
were compared with ovaries of 4- or 6-d-old mice, respec-
FIG. 1. Western blot analysis of concentrated wild-type HEK293 and
rat AMH-producing HEK293 cells. No AMH protein expression is
found in concentrated medium of wild-type HEK293 cells (lane 1),
whereas AMH protein is found in concentrated medium of rat AMH-
producing HEK293 cells (lane 2).
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tively. The most significant difference was a larger diameter
of primary follicles in ovaries cultured for 2 d than primary
follicles in 4-d-old ovaries (Fig. 2C), whereas follicle devel-
opment in ovaries cultured for 4 d were not different from
ovaries from 6-d-old mice (Fig. 2E). It also seems that more
follicles reach the primary stage in ovaries cultured for 2 d
than in 4-d-old ovaries. However, no direct statements re-
garding the numbers can be made because no follicle count-
ing was performed in the freshly isolated ovaries.
The presence of AMH in the culture medium did not have
detrimental effect on the tissue of the cultured ovaries (re-
sults not shown).
AMH and inhibin -subunit immunohistochemistry
To further evaluate the condition of the cultured ovaries
and to determine the onset of AMH and inhibin -subunit
protein expression in vivo, an immunohistochemical study
was performed on freshly isolated 1- to 6-d-old mouse ova-
ries, and in ovaries from 2-d-old mice cultured for 2 or 4 d.
In freshly isolated ovaries of 2-d-old mice, containing na-
ked oocytes, primordial follicles, or interstitial tissue no spe-
cific AMH protein expression was detected (Fig. 3A). In vivo
AMH protein expression was first found in a few granulosa
cells of the smallest primary follicles from 4-d-old mice (Fig.
3C), whereas in larger primary follicles all granulosa cells
show AMH protein expression. High AMH protein expres-
sion was found in the granulosa cells of primary and early
secondary follicles of 6-d-old mice (Fig. 3E).
Cultured ovaries exhibited an identical AMH expression
pattern compared with freshly isolated ovaries, i.e. expres-
sion was found in granulosa cells of primary and secondary
follicles. However, the expression level of AMH was higher
in the primary follicles of ovaries cultured for 2 d than that
in freshly isolated ovaries of 4-d-old animals (compare Fig.
3, C and G). No difference was found in AMH protein ex-
pression level between freshly isolated 6-d-old ovaries and
ovaries cultured for 4 d (results not shown). The negative
control showed that some background staining was found in
the oocytes and in the interstitium (Fig. 3I).
The inhibin -subunit protein expression pattern was
identical to the AMH protein expression both in vivo and in
vitro (Fig. 3, B–J), although the inhibin -subunit protein
expression was somewhat less abundant. A very low amount
of background staining was found in the oocytes (Fig. 3J).
The presence of AMH in the culture medium did not affect
the expression of either AMH or inhibin -subunit (results
not shown).
Histological and immunohistochemical evaluation of cul-
tured and freshly isolated ovaries of comparable age re-
vealed that follicle development in vivo and in vitro are sim-
ilar, and therefore our neonatal ovary organ culture system
FIG. 2. Photomicrographs of cultured
and noncultured neonatal mouse ovaries.
A, Section of an ovary of a 2-d-old mouse.
Many primordial follicles (pr) and some
“naked” oocytes (no) are present. Scale
bar, 20 m. B, Section of a 2-d-old mouse
ovary cultured for 2 d. The present culture
conditions had no detrimental effect on
tissue quality because almost no necrotic
and apoptotic cells were found. Most pri-
mordial follicles are located in the cortex
of the ovary, whereas the primary and
secondary follicles are predominantly
found in the central part of the ovary.
Scale bar, 50 m. C, Section of an ovary of
a 4-d-old mouse. Many primordial (pr) and
some primary (P) follicles are found. Scale
bar, 20 m. D, Section of a 2-d-old mouse
ovary cultured for 2 d. After 2 d of culture
the ovaries contained many primordial
follicles (pr) and primary follicles (P) of
different sizes. Scale bar, 20 m. E, Sec-
tion of an ovary of a 6-d-old mouse. Be-
sides primordial (pr) and primary (P) fol-
licles, also some early secondary (S)
follicles are present. Scale bar, 20 m. F,
Section of an ovary of a 2-d-old mouse cul-
tured for 4 d. In addition to primordial (pr)
and primary (P) follicles, also some early
secondary follicles are found (S) (C). Scale
bar, 20 m.
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FIG. 3. Immunohistochemical localiza-
tion of AMH and inhibin -subunit in
freshly isolated (control) and cultured neo-
natal C57Bl/6J mouse ovaries. A and B,
Section of a 2-d-old control mouse ovary.
No AMH (A) and inhibin -subunit (B) pro-
tein expression is found in naked oocytes
(no), primordial follicles (pr), and intersti-
tial tissue (I). Scale bar, 20 m. C and D,
Section of a 4-d-old control mouse ovary.
AMH protein expression (C) and inhibin
-subunit protein expression (D) are found
in several granulosa cells of early primary
follicles. Scale bar, 20m. E and F, Section
of a 6-d-old control mouse ovary. Abundant
AMH protein expression (E) and inhibin
-subunit protein expression (F) are found
in granulosa cells of primary follicles (P)
and early secondary follicles (S). Scale bar,
20 m. G and H, Section of a 2-d-old mouse
ovary cultured for 2 d in the absence of
added AMH. High AMH protein expres-
sion (G) and inhibin -subunit protein ex-
pression (H) are found in granulosa cells of
primary follicles (P). Scale bar, 20 m. I
and J, Section of a 4-d-old control mouse
ovary. For AMH some background staining
is found in the interstitium (I) and the oo-
cytes, whereas for inhibin -subunit very
low background staining is only found in
the oocytes (J). Scale bar, 20 m.
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was applied to examine the effect of AMH on the initiation
of primordial follicle recruitment.
Effect of AMH on initiation of primordial follicle growth
To determine the effect of AMH on the recruitment of
primordial follicles, the numbers of primordial, primary and
secondary (growing) follicles were counted in ovaries cul-
tured for 2 or 4 d in the absence or presence of AMH.
In the ovarian culture experiment, the effect of different
culture conditions (/ AMH) were tested by comparing
the number of primordial and growing follicles between
ovaries derived from the same animal (paired ovaries) be-
cause no large differences exist in the number of primordial
follicles between two ovaries derived from the same animal
(results not shown). To optimize the contact between the
ovarian tissue and the culture medium, the periovarian sac
was removed before the 2-d-old ovaries were used in the
ovarian culture experiments. To test whether the removal of
the periovarian sac has any impact on the number of pri-
mordial follicles, the number of primordial follicles was
counted in paired ovaries of two 2-d-old mice, of which of
one of the ovaries the periovarian sac was removed. Removal
of the periovarian sac resulted in the loss of primordial fol-
licles because approximately 3000 (2982  53) primordial
follicles were found in 2-d-old ovaries with the periovarian
sac in place, and about 1400 (1384  37) after removal of the
periovarian sac.
After 2 or 4 d of culture, no difference was found in the
total number of follicles per cultured ovary, when the ovaries
were derived from the same female (results not shown).
However, variation did occur between cultured ovaries iso-
lated from different animals. This interanimal variation was
mainly due to a difference in the number of primordial fol-
licles, ranging from 691–2281 primordial follicles per ovary.
Moreover, primordial follicles were also lost during the cul-
ture period because significantly more primordial follicles
were found in the ovaries after 2 d of culture (1893  104)
than after 4 d of culture (1401  79).
The total numbers of primordial and growing follicles after
2 and 4 d of culture in the presence or absence of AMH are
shown in Table 1. After both 2 and 4 d of culture, no effect
of AMH on the number of primordial follicles was found.
However, significantly fewer growing follicles were found in
the AMH-treated ovaries compared with the control ovaries.
After normalization to percentages, we found that after 2 d
of culture the number of growing follicles cultured in the
presence of AMH was approximately 59 4% of the control
(Fig. 4A), whereas after 4 d of culture this was approximately
66  6% (Fig. 4B).
After 2 d of culture, for both treatment groups, most grow-
ing follicles reached a diameter of 30m and some a diameter
of 40 m. After 4 d of culture, most growing follicles reached
a diameter of 40 m and some a diameter of 50 m. The
presence of AMH did not affect the maximal diameter
reached by the follicles during the culture period.
RNase protection assay
To investigate whether the decrease in number of growing
follicles was reflected in the levels of expression of mRNA for
markers of follicle differentiation, the mRNA expression
level for the granulosa cell markers, inhibin -subunit and
AMHRII, and for the oocyte-specific markers, GDF-9 and
ZP3, in freshly isolated 2-, 4-, and 6-d-old ovaries and in
cultured ovaries was examined using RNase protection as-
say. Total RNA from 30-d-old mice was used as a control.
PhosphorImager analysis of the RNase protection assay is
shown in Fig. 5, A and B. Quantitative analysis revealed that
AMHRII mRNA expression is present in all ovaries exam-
ined and does not change with age or under different culture
conditions (Fig. 5C). The mRNA expression level of inhibin
-subunit increased from d 2 to d 6. In the ovaries cultured
for 2 d in the presence of AMH, a decrease in inhibin -
subunit expression level of 68% was found, compared with
the ovaries cultured in the absence of AMH. After 4 d of
culture this decrease was 46% (Fig. 5C).
In the freshly isolated ovaries an increase in the mRNA
expression level from d 2 to d 6 was found for both oocyte-
specific markers (GDF9 and ZP3). No difference was found
in mRNA expression level between ovaries cultured in the
presence or absence of added AMH, although a slight de-
crease was found for ZP3 expression after 2 d of culture in
the presence of AMH (Fig. 5C).
Discussion
In the mouse, primordial follicles are formed just after
birth, and this pool of primordial follicles constitutes the
TABLE 1. The number of primordial and growing follicles after 2
and 4 d of culture in the absence or presence of added AMH
Days of culture / AMH No. of primordialfollicles
No. of growing
follicles
2 (N  9)  AMH 1968  82 81  4
2 (N  9)  AMH 1808  141 50  2a
4 (N  11)  AMH 1369  148 153  8
4 (N  11)  AMH 1434  155 97  8a
The numbers of follicles found in two independent experiments are
pooled and shown as mean SEM (P 0.05). a Indicates a significant
difference from the control. N, Number of ovaries examined.
FIG. 4. Growing follicles as a percentage of the control in 2-d-old
mouse ovaries cultured for 2 d (A) or 4 d (B) in the absence or presence
of AMH. The number of growing follicles found in ovaries cultured in
the presence of AMH is shown as a percentage of the control. N
represents the number of ovaries that were investigated. Data rep-
resent the mean  SEM. The asterisks indicate a statistically signif-
icant difference (P  0.05).
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complete supply of ovarian follicles during reproductive life.
Initiation of primordial follicle growth occurs from the mo-
ment that these follicles arise in the ovary, although not all
primordial follicles start to grow at the same time and some
will remain dormant for months in rodents (2, 3) and even
for years in the human (1). The factors that regulate this
initiation of primordial follicle growth are still largely un-
known. Recently, it was shown in a culture system for neo-
natal rat ovaries that SCF and bFGF can stimulate the re-
cruitment of primordial follicles (5, 7), whereas in vitro
treatment with GDF9 enhances the progression of primordial
and primary rat follicles into small preantral follicles (6).
Studying the follicle population of NGF-deficient mice re-
vealed that in these mice fewer primary follicles were
formed, whereas an almost normal complement of primor-
dial follicles existed, suggesting that NGF is important for the
initiation of primordial follicle growth (8). These are the first
studies, which show that ovarian growth factors play an
important role in initiation of primordial follicle growth. In
our study of ovaries from AMH-deficient females, it became
evident that also AMH affects initiation of primordial follicle
growth (9).
In the present study, the effect of AMH on primordial
follicle recruitment was tested using ovaries from 2-d-old
mice in a neonatal ovary organ culture system. Ovaries of
2-d-old mice provide a useful system for the study of factors
FIG. 5. Effect of AMH on expression of GDF9, ZP3, AMHRII, and inhibin -subunit mRNAs. A and B, PhosphorImager analysis of a
representative RNase protection assay for inhibin-subunit and GAPDH mRNA expression (A) and for ZP3, AMHRII, GDF9 and GAPDH mRNA
expression (B) in neonatal ovaries of 2-, 4-, and 6-d-old control mice, and in 2-d-old ovaries cultured for 2 or 4 d in the presence () or absence
() of AMH. RNA from 30-d-old mice is used as a control. C, Quantification of inhibin -subunit, ZP3, AMHRII, and GDF9 mRNA levels in
2-, 4-, and 6-d-old control mouse ovaries, and in 2-d-old mouse ovaries cultured for 2 or 4 d in the absence or presence of added AMH. All these
mRNA levels were normalized to that of GAPDH mRNA. Values are represented as a percentage of 2-d-old ovaries (considered 100%) and are
the mean  SEM of two independent experiments. For every culture condition, total RNA of 20 ovaries was pooled, whereas total RNA of 20
ovaries of 2-, 4-, and 6-d-old animals and of 5 ovaries of 30-d-old animals were pooled.
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that influence the initiation of primordial follicle growth
because they contain many primordial follicles, only few
naked oocytes, and no growing follicles. In this culture sys-
tem, not all primordial follicles started to grow, but similar
to observations in vivo (24) and in another ovary culture
system (25), some of the primordial follicles located in the
central part of the ovary were the first to initiate growth.
After 2 and 4 d of culture, fewer growing follicles were
found in ovaries cultured in the presence of AMH than in the
control ovaries, which indicates that AMH indeed inhibits
initial recruitment. By immunohistochemistry it was shown
that AMH is already produced by early primary follicles,
making AMH a very early marker of ovarian follicle growth.
This means that from postnatal d 4, about 1 d after the first
primary follicles are formed in mouse ovaries, these ovaries
produce a small amount of AMH. Also in the cultured ova-
ries, endogenous AMH was found in the early primary fol-
licles that arise after 1 d of culture. Therefore, the effect of
AMH found in the culture model may be an underestimation
of the actual effects.
To exclude the possibility that the lower number of grow-
ing follicles found in AMH-treated ovaries is caused by an
AMH-induced retardation of early primary follicle growth,
we also looked at the maximal mean diameter that was
reached in control and AMH-treated ovaries. Because under
both culture conditions the growing follicles reached the
same maximal diameter, we conclude that AMH has no effect
on the pace of early primary follicle growth.
The inhibition of initiation of primordial follicle growth
is probably due to a direct effect of AMH on the primor-
dial follicle. Using RNase protection assay, we show that
AMHRII mRNA expression, essential for an effect of AMH,
is present in ovaries of 2-d-old mice. In both mouse and rat,
ovarian AMHRII mRNA expression is even found before
birth (our observations) (13, 14). In addition, in situ hybrid-
ization studies showed ovary-specific AMHRII expression in
neonatal ovaries. However, exact localization of the radio-
active AMHRII probe to the pregranulosa cells was not pos-
sible because this probe is best visualized using a microscope
with darkfield, whereby it is very difficult to discern specific
structures or cell types in neonatal ovaries (13) (Durlinger,
A. L. L., unpublished observations). At later stages of ovar-
ian development, AMHRII expression is limited to the gran-
ulosa cells of mainly nonatretic preantral and small antral
follicles (13) (Durlinger, A. L. L., unpublished observations),
although recently AMHRII transcripts have also been de-
tected in the internal theca cell layer of preantral follicles (16).
As soon as primordial follicle growth is initiated, as in-
dicated by a change in appearance of the pregranulosa cells,
not only AMH, but also -inhibin protein is produced by the
granulosa cells of the early primary follicles and the inhib-
itory effect of AMH on primordial follicle recruitment is
reflected by a decrease in -inhibin, used as a marker of early
follicle development. However, a functional role of -inhibin
produced by these primary follicles is unclear at the present.
More insight in the role of inhibin in early follicle develop-
ment could come from detailed analysis of the follicle pop-
ulation of inhibin-deficient females, before they develop
ovarian tumors (26).
The number of primordial follicles that start to grow
within a certain time period was not dependent on the total
number of primordial follicles present in the ovary at the
beginning of the culture experiment. It appears that within
a certain time period the same number of primordial follicles
starts to grow, irrespective of the size of the pool of primor-
dial follicles. The same result was found in another in vitro
study in which prenatal and neonatal mouse ovaries were
placed in culture (27). Krarup et al. (28), however, state that
their in vivo study shows that the fraction of a pool of pri-
mordial follicles that initiate growth does depend on the
actual size of the pool primordial follicles. The discrepancy
between our results and of Byskov et al. (27) and the results
of Krarup et al. (28) could be explained by the fact the ovarian
culture experiments are in vitro studies, in which many pos-
sible factors influencing the initiation of primordial follicle
growth are eliminated, while Krarup et al. (28) performed an
in vivo study.
Although the amount of AMH (800 U/ml) used in the
herein described culture experiments caused complete Mu¨l-
lerian duct regression in vitro (Durlinger, A. L. L., unpub-
lished observations), the recruitment of primordial follicles
was not completely blocked. This observation is in accor-
dance with the findings in AMH-deficient females, in which
not all primordial follicles initiated growth. Thus, AMH is
not the only regulator of initial recruitment. Indeed, the
stimulatory effect of SCF (5), GDF9 (6), bFGF (7), and NGF
(8) on the initiation of primordial follicle growth show that
activation of primordial follicle growth is under the influence
of both stimulatory and inhibitory regulation. It would be
interesting to culture neonatal ovaries with SCF, GDF9,
bFGF, or NGF in the presence of AMH to study the possible
functional interactions on initial recruitment. Indications for
an interaction between SCF and GDF9 already exist because
SCF mRNA expression is highly elevated in mice lacking
GDF9, suggesting that GDF9 is one of the oocyte-secreted
factors that negatively regulate SCF expression (29). Besides
AMH, SCF, GDF9, bFGF, and NGF, probably many other as
yet unidentified factors are involved, and their role in initial
recruitment is still not established. Identification of receptors
for hormones and growth factors expressed by either the
oocyte or the pregranulosa cells of primordial follicles will
give more insight in the process of initial recruitment.
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